Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury.
about
The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ TransplantationKidney xenotransplantationCardiac purinergic signalling in health and diseaseComplete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient miceSimultaneous Overexpression of Functional Human HO-1, E5NT and ENTPD1 Protects Murine Fibroblasts against TNF-α-Induced Injury In VitroTransgenic swine: expression of human CD39 protects against myocardial injury.Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?Hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set point for fibrotic activity of cardiac fibroblasts.The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury.CD39: Interface between vascular thrombosis and inflammation.Interleukin-17A Exacerbates Ferric Chloride-Induced Arterial Thrombosis in Rat Carotid Artery.Kcnj11 Ablation Is Associated With Increased Nitro-Oxidative Stress During Ischemia-Reperfusion Injury: Implications for Human Ischemic Cardiomyopathy.Ectonucleotidase CD39-driven control of postinfarction myocardial repair and rupture.ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk.CD39-adenosinergic axis in renal pathophysiology and therapeutics.
P2860
Q21131166-9E0E4701-E067-41AD-8102-01CE8EB4BFAFQ26822638-6E7EACF8-BD7D-441E-B672-2D1A904C8AC6Q33165093-BE97FF34-2B00-49EC-B3C4-218994D309FBQ33867669-26451EE5-1E85-4E47-9895-C6868DE2EB24Q35826059-DF0977F4-EE2A-4072-8FEE-56B2C6D0EE80Q35892406-67C5502F-4C3A-41BE-A51B-D107EE561714Q36071796-38E685EC-889E-406A-A2ED-099A5F646112Q36779378-7A79072B-2EDC-41C7-ACE2-CD384F410BCFQ36967345-154A2D12-FD61-45CE-8C33-51BC01626F9BQ38063159-C9396F26-EC2A-40BC-B7E0-042BE09514B9Q38212581-3EF25700-7E32-4C12-A879-253F591144ECQ38922494-9100AFDF-2184-487B-A9B3-3D1173664427Q38956427-9BAC9828-19F5-40D0-9A8B-C3CAC3EBFB8AQ40766858-58E4F374-AE3A-455E-8050-C4FB1C3B057FQ41628315-F334677A-C005-42F7-A55E-8D57E9E17A28Q43102079-F5891622-35AE-44AD-B9C5-92C176329C29Q47655859-A38D72A6-143A-4482-9C04-AE4FEE75D91C
P2860
Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Transgenic over expression of ...... ne myocardial ischemic injury.
@ast
Transgenic over expression of ...... ne myocardial ischemic injury.
@en
type
label
Transgenic over expression of ...... ne myocardial ischemic injury.
@ast
Transgenic over expression of ...... ne myocardial ischemic injury.
@en
prefLabel
Transgenic over expression of ...... ne myocardial ischemic injury.
@ast
Transgenic over expression of ...... ne myocardial ischemic injury.
@en
P2093
P2860
P1476
Transgenic over expression of ...... ine myocardial ischemic injury
@en
P2093
Anthony J F d'Apice
Debra G Wheeler
Guanglong He
Jay L Zweier
Karen M Dwyer
Lauren A Goodman
Lawrence J Druhan
P2860
P304
P356
10.1016/J.YJMCC.2011.09.003
P50
P577
2011-09-12T00:00:00Z